Former Gates Foundation and Baxter Executive Peter H. Khoury, Ph.D. Joins Nanotherapeutics as Chief Commercial Officer
ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that Peter Khoury, Ph.D. has joined the Company as Senior Vice President and Chief Commercial Officer, effective August 1, 2016.
“We are delighted to welcome Peter, a highly seasoned executive with proven sales and marketing skills, as our Chief Commercial Officer,” stated James M. Matthew, President, Chief Executive Officer and Chief Financial Officer of Nanotherapeutics, Inc. “Having worked in the healthcare and life sciences industries for more than 20 years with several of the largest, most influential and respected global organizations, Peter’s expertise and relationships make him a perfect fit for Nanotherapeutics. In this new position, Peter’s experience will be invaluable as we execute on our strategic plan, including an emphasis on commercial full-scale manufacturing, which is expected to significantly increase our customer base and revenue stream going forward.”